DERM Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 111903 min ago

@ $4.83

Išleistas: 13 vas. 2024 @ 16:36

Grąža: -23.60%

Ankstesnis signalas: vas. 6 - 20:59

Ankstesnis signalas: Pardavimas

Grąža: 10.02 %

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 23:00):

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
Šios dienos apimtis	98 294.00
Vidutinė apimtis	163 535
Rinkos kapitalizacija	73.55M
EPS	$0 ( 2024-03-21 )
Kita pelno data	( $-0.260 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-17.57
ATR14	$0.0330 (0.91%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Rosenwald Lindsay A Md	Buy	10 000	Common Stock, $0.0001 par value
2024-03-22	Maraoui Claude	Buy	10 000	Common Stock, $0.0001 par value
2024-03-22	Smith Justin Adam	Buy	30 000	Common Stock, $0.0001 par value
2024-03-22	Rosenwald Lindsay A Md	Buy	20 000	Common Stock, $0.0001 par value
2024-02-22	Benesch Joseph	Sell	2 450	Common Stock, $0.0001 par value

INSIDER POWER
75.70
Last 94 transactions
Buy: 1 155 250 \| Sell: 1 927 470

Tūris Koreliacija

Ilgas: -0.15 (neutral)

Trumpas: -0.66 (moderate negative)

Signal:(49.212) Neutral

Dermira Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
RMRM	0.942
VVOS	0.891
GETVV	0.878
XCUR	0.854
GAINL	0.846
ACST	0.825
GLMD	0.825
PASG	0.809

10 Labiausiai neigiamai susiję koreliacijos
AMRB	-0.849
OZK	-0.815
SJ	-0.814

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Dermira Inc. Koreliacija - Valiuta/Žaliavos

0.84
( strong )

0.00
( neutral )

0.42
( neutral )

-0.52
( weak negative )

Dermira Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$79.18M
Bruto pelnas:	$52.52M (66.33 %)
EPS:	$-0.210

FY	2023
Pajamos:	$79.18M
Bruto pelnas:	$52.52M (66.33 %)
EPS:	$-0.210

FY	2022
Pajamos:	$73.67M
Bruto pelnas:	$42.89M (58.23 %)
EPS:	$-1.690

FY	2021
Pajamos:	$63.13M
Bruto pelnas:	$31.05M (49.18 %)
EPS:	$-2.68

Financial Reports:

No articles found.

Dermira Inc.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.